| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |